Organization
Zhang Bi Xiang, MD
1 clinical trial
Clinical trial
A Single-center, Single-arm, Non-randomized Clinical Study to Evaluate the Efficacy and Safety of Hyperbaric Oxygen Therapy Plus Camrelizumab as a Second-line Treatment in Advanced/Metastatic Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-12-31